Hayashi N, Hayama K, Takahashi K, Kurokawa I, et al. Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12-week interim analysis of post-marketing surveillance in Japan. J Dermatol 2022;49:411-421.
PMID: 35040156